Free tool
FAERS Monitor: Reglan
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017854 or its brand name (Reglan, Metoclopramide Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
77,180
Serious
69,461
90% of reports
Hospitalization
34,338
Death reported
9,975
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- tardive dyskinesia16,216
- extrapyramidal disorder12,921
- nervous system disorder7,526
- dystonia7,115
- nausea6,547
- pain5,998
- vomiting4,989
- diarrhoea4,164
- anxiety4,091
- economic problem3,962
- incorrect drug administration duration3,710
- fatigue3,614
- dyspnoea3,307
- movement disorder3,272
- dyskinesia3,214
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,145 |
| 2005 | 1,207 |
| 2006 | 1,167 |
| 2007 | 1,134 |
| 2008 | 1,315 |
| 2009 | 1,732 |
| 2010 | 2,835 |
| 2011 | 12,666 |
| 2012 | 7,303 |
| 2013 | 2,666 |
| 2014 | 2,319 |
| 2015 | 2,550 |
| 2016 | 2,948 |
| 2017 | 2,755 |
| 2018 | 3,701 |
| 2019 | 4,071 |
| 2020 | 3,888 |
| 2021 | 4,264 |
| 2022 | 4,266 |
| 2023 | 3,846 |
| 2024 | 3,498 |
| 2025 | 3,286 |
| 2026 | 2,601 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,976,979 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| tardive dyskinesiaSignal | 16,216 | 366.5 | 358.4 | 2,520,252 |
| extrapyramidal disorderSignal | 12,921 | 294.2 | 287.3 | 1,815,039 |
| dystoniaSignal | 7,115 | 157.2 | 152.8 | 700,241 |
| economic problemSignal | 3,962 | 96.1 | 92.7 | 275,491 |
| nervous system disorderSignal | 7,526 | 86.3 | 84.2 | 482,217 |
| incorrect drug administration durationSignal | 3,710 | 41.2 | 39.9 | 126,636 |
| movement disorderSignal | 3,272 | 30.8 | 29.7 | 84,853 |
| dyskinesiaSignal | 3,214 | 23.3 | 22.5 | 63,321 |
| anxietySignal | 4,091 | 4.0 | 3.8 | 9,041 |
| vomitingSignal | 4,989 | 2.9 | 2.8 | 6,336 |
| painSignal | 5,998 | 2.7 | 2.6 | 6,427 |
| nauseaSignal | 6,547 | 2.3 | 2.2 | 4,764 |
| diarrhoea | 4,164 | 1.8 | 1.7 | 1,408 |
| dyspnoea | 3,307 | 1.6 | 1.5 | 750 |
| fatigue | 3,614 | 1.3 | 1.2 | 209 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.